A prospective, randomized, double-blind and placebo-controlled, parallel group, phase II study to compare the efficacy and safety of candesartan versus placebo on cognitive impairment associated with Parkinson's disease. Exploratory study.
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 30 Jun 2016 New trial record